| PhaseOneTrials A/S is a Danish Contract Research Organization (CRO)
that conducts highly specialized clinical phase I trials and early phase
II trials of new drug candidates. |
| |
| Phase I trials include studies in which a new drug is tested for the
first time in healthy humans – also known as “First-in-Man”
studies. Early phase II studies, or “Proof-of-Concept” studies,
include testing a drug in small groups of patients to determine whether
the drug has the desired effects on a given disease. |
| |
| PhaseOneTrials has extensive experience planning and conducting ”First-in-Man”
trials for both classical pharmaceutical and new biological drugs. We
have worked with recombinant peptide hormones, enzymes and growth factors.
Our location at a university hospital, proximity to their intensive care
unit and collaboration with distinguished specialists all mean that we
easily meet the increasing government safety requirements for such trials. |
| |
| Our clients are Scandinavian and international biotech and pharmaceutical
companies that are looking for more efficient, profitable and safe development
processes for new drugs. |
| |
PhaseOneTrials specializes in conducting complicated studies which are
tailor-made to each customer’s specific requirements. This customized
process ensures optimal study results, based on data
of the highest quality.
PhaseOneTrials has strong competencies and significant experience in several
areas: |
- Metabolic disorders
- Brain and nerve diseases
- Skin diseases
- Inflammatory diseases and infections
- Rare diseases
- Children’s diseases
|
| With its unique location at Hvidovre University
Hospital, PhaseOneTrials provides contract research in a very secure
and competent environment with immediate access to the hospital’s
functions and services. All studies are carried out by professional, specially
educated PhaseOneTrials staff
and in close dialogue with our close-knit network
of medical advisors. |
|  |
 |
